Belite Bio files Form 144 for option exercises

Belite Bio, Inc. submitted Form 144 entries that show exercises-and-hold of stock options resulting in 1,400 shares on 08/26/2024 and 8,796 shares on 02/26/2025.

Accepted by SEC EDGAR 04/09/2026 - 12:17 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Belite Bio, Inc. submitted Form 144 entries that show exercises-and-hold of stock options resulting in 1,400 shares on 08/26/2024 and 8,796 shares on 02/26/2025. The filing lists Common Stock and identifies J.P. Morgan Securities LLC as a broker.

Key Figures

Exercise resulting shares: 1,400 shares Exercise resulting shares: 8,796 shares Form reference date: 04/09/2026

3 metrics

Exercise resulting shares 1,400 shares exercise-and-hold on 08/26/2024

Exercise resulting shares 8,796 shares exercise-and-hold on 02/26/2025

Form reference date 04/09/2026 Form 144 filing date shown in header

Key Terms

Form 144, Exercise and Hold of Stock Options, Common Stock

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise and Hold of Stock Options financial

"Exercise and Hold of Stock Options | Belite Bio, Inc (issuer)"

Common Stock financial

"Securities To Be Sold Common |"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Belite Bio (BLTE) report on Form 144?

Form 144 lists proposed transactions in restricted or control securities. This filing records exercises-and-hold of options producing 1,400 shares on 08/26/2024 and 8,796 shares on 02/26/2025, and names J.P. Morgan Securities LLC as the broker.

Do the Form 144 entries for BLTE show open-market sales?

The entries describe Exercise and Hold of Stock Options, not explicit open-market sales. The filing lists the resulting share counts but does not state executed brokered sales in the provided excerpt.

Who is the broker listed on the BLTE Form 144?

The broker identified in the excerpt is J.P. Morgan Securities LLC, with an address at 270 Park Ave, 10th Floor, New York, NY. No further broker instructions or sale methods are shown in the excerpt.

What dates are tied to the reported option exercises in BLTE's filing?

The filing ties 1,400 shares to an exercise-and-hold dated 08/26/2024 and 8,796 shares to an exercise-and-hold dated 02/26/2025. No sale closing dates are provided in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002001438
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Belite Bio, Inc
SEC File Number	001-41359
Address of Issuer	12750 High Bluff Drive Suite 475 San Diego CALIFORNIA 92130
Phone	8582466240
Name of Person for Whose Account the Securities are To Be Sold	Wan Shan Chen
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Ave 10th Floor New York NY 10017	10196	2220250	37514630	04/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/26/2024	Exercise and Hold of Stock Options	Belite Bio, Inc (issuer)			1400	08/26/2024	cash
Common	02/26/2025	Exercise and Hold of Stock Options	Belite Bio, Inc (issuer)			8796	02/26/2025	cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	04/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	J.P. Morgan Securities LLC , Workplace Solutions, as agent and attorney-in-fact for Wan Shan Chen, Belite Bio
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)